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Biallelic FAM20A mutations cause two conditions where Amelogenesis Imper-
fecta (AI) is the presenting feature: Amelogenesis Imperfecta and Gingival Fib-
romatosis Syndrome; and Enamel Renal Syndrome. A distinctive oral
phenotype is shared in both conditions. On Sanger sequencing of FAM20A in
cases with that phenotype, we identified two probands with single, likely patho-
genic heterozygous mutations. Given the recessive inheritance pattern seen in
all previous FAM20A mutation-positive families and the potential for renal dis-
ease, further screening was carried out to look for a second pathogenic allele.
Reverse transcriptase-PCR on cDNA was used to determine transcript levels.
CNVseq was used to screen for genomic insertions and deletions. In one family,
FAM20A cDNA screening revealed only a single mutated FAM20A allele with
the wild-type allele not transcribed. In the second family, CNV detection by
whole genome sequencing (CNVseq) revealed a heterozygous 54.7 kb duplica-
tion encompassing exons 1 to 4 of FAM20A. This study confirms the link
between biallelic FAM20A mutations and the characteristic oral phenotype. It
highlights for the first time examples of FAM20A mutations missed by the most
commonly used mutation screening techniques. This information informed
renal assessment and ongoing clinical care.
Introduction
Biallelic FAM20A mutations cause Amelogenesis Imperfec-
ta (AI) and Gingival Fibromatosis Syndrome (AIGFS,
OMIM: 614253) (O’Sullivan et al. 2011) and Enamel Renal
Syndrome (ERS, OMIM: 204690) (Jaureguiberry et al.
2012; Wang et al. 2013). Both disorders involve hypoplastic
AI in the primary and secondary dentitions, together with
variable degrees of gingival hyperplasia, pulpal calcifica-
tions, and delayed tooth eruption (de la Dure-Molla et al.
2014). In addition, nephrocalcinosis may subsequently
develop with a variable age of onset that is incompletely
defined. A total of 36 pathogenic FAM20A variants identified
by Sanger sequencing have been published, including stop-
gain, frameshift, missense, and splice-site mutations (Cho
et al. 2012; Cabral et al. 2013; Kantaputra et al. 2014a,b;
Wang et al. 2014; Cherkaoui Jaouad et al. 2015; Volodarsky
et al. 2015). Some patients diagnosed with AIGFS have sub-
sequently been recognized to have nephrocalcinosis. It has
therefore been suggested that recessive FAM20A mutations
are responsible for a single disease which should now be
termed ERS (de la Dure-Molla et al. 2014).
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FAM20A is a member of a family of three homologous
proteins, FAM20A, B, and C, known as the atypical
secretory serine kinase family with sequence similarity 20.
FAM20C is a Golgi casein kinase that phosphorylates key
extracellular molecules involved in biomineralization (Tag-
liabracci et al. 2012), and mutations in the encoding gene
(OMIM: 611061) cause recessively inherited Raine syn-
drome (OMIM: 259775) (Simpson et al. 2007). The oral
phenotypes observed in individuals with either recessive
mutations in FAM20A or FAM20C share features and may
appear isolated in milder or earlier stages of disease (de la
Dure-Molla et al. 2014; Acevedo et al. 2015). Identification
of the pathogenic mutation in these cases may therefore
require sequencing of both genes. FAM20B, not as yet
unequivocally associated with any inherited human condi-
tion, has been shown to be a Golgi kinase with a key role in
phosphorylating xylose in glycosaminoglycan-protein link-
age region of proteoglycans. By comparison, little is known
of FAM20A function. It is predicted to be a kinase with tar-
gets specific to mineralization, calcium transport, and pro-
teoglycan synthesis (de la Dure-Molla et al. 2014), but this
remains to be confirmed experimentally. As such, FAM20A
may have additional unknown functions. A recent study by
Cui et al., however, suggests FAM20A lacks catalytic activ-
ity and therefore should be categorized as a pseudokinase
(Cui et al. 2015). Instead they found FAM20A-regulated
phosphorylation of targets via activation of FAM20C. By
forming a complex, kinase activity was enhanced leading to
high levels of substrate phosphorylation. In cells lacking
FAM20A, FAM20C kinase activity was inhibited. While
further studies are required to understand this mechanism
further, the identification of recessively inherited mutations
in FAM20A as a cause of AIGFS and ERS suggests a key
involvement of this protein in biomineralization.
In this study, we further investigated two families for
whom only a single heterozygous missense mutation in
FAM20A had been identified by Sanger sequencing of geno-
mic DNA. The pathognomonic oral phenotype and autoso-
mal recessive inheritance of FAM20A mutations strongly
suggested the existence of a second deleterious allele. We
therefore applied two further mutation detection screens;
reverse transcriptase (RT)-PCR to examine the FAM20A
transcript and low-coverage whole genome sequencing
(CNVseq) which was used to identify dosage variants at the
FAM20A locus. Using these approaches we were able to
identify the second pathogenic alleles in both probands,
which were undetected using standard Sanger sequencing.
These findings had implications for ongoing clinical care.
Materials and Methods
Affected individuals and relatives were recruited following
informed consent in accordance with the principles
outlined in the declaration of Helsinki, with local ethical
approval. Genomic DNA samples were obtained using
either Oragene DNA sample collections kits (DNA
Genotek, Ontario, Canada) or via venous blood samples,
using conventional techniques. Genomic DNA was
extracted by salt (blood) or ethanol (saliva) precipitation.
Exons and flanking intronic sequences of FAM20A and
FAM20C were amplified by the polymerase chain reaction
(PCR) according to standard protocols. Primers were
designed using ExonPrimer software (http://ihg.gsf.de/ihg/
ExonPrimer.html) and are listed in Table S1.
Patient blood obtained for RNA transcript analysis was
immediately stabilized with EDTA. RNA was extracted
using the QIAamp RNA Blood Mini Kit system (Qiagen,
Hilden, Germany). First-strand cDNA synthesis was per-
formed using the Moloney murine leukemia virus (M-
MLV) reverse transcriptase (Life Technologies, Carlsbad,
CA) according to the suppliers’ recommended instructions.
Copy number variant detection using low-coverage
whole genome sequencing data was performed as previ-
ously described (Wood et al. 2010; Watson et al. 2014).
One microgram of genomic DNA was sheared using a
Covaris S2 (Covaris, Inc., Woburn, MA) before Illumina
compatible sequencing libraries were generated using
NEBNext UltraTM reagents (New England Biolabs, Ips-
wich, MA), following manufacturer’s instructions.
Twenty million single end 50-bp reads were obtained for
each sample using a HiSeq 2500 run in rapid mode.
Raw sequence reads were aligned to an indexed human
reference genome (hg19) using the Burrows–Wheeler
aligner (bwa) v0.6.2 (Li and Durbin 2009) and duplicate
reads were discarded using Picard v1.85 (http://pi-
card.sourceforge.net). Coordinates of uniquely mapped
test and reference reads were extracted from BAM files
(Li et al. 2009) and counted into genomic windows con-
taining equal numbers of reference reads. A read count
adjustment was performed to compensate for the effect
of local GC% variation, and the adjusted ratios of test to
reference read counts were used as input to the R mod-
ule DNAcopy v1.32.0 (Venkatraman and Olshen 2007),
which segments the data into regions of equal copy
number.
Whole exome sequencing was performed using 3 lg of
genomic DNA with the SureSelect All Exon v5 reagent
according to the manufacturer’s protocol. Sequencing was
performed on an Illumina HiSeq 2500 across two lanes of
a rapid mode flow cell using a 100 bp paired-end proto-
col. Raw sequence reads for a pool of six exome libraries
were demultiplexed and aligned to hg19 using bwa v0.6.2.
Picard v1.85 removed duplicate reads. Dosage analysis
was performed using FishingCNV (Shi and Majewski
2013) by comparing this sample to a cohort of 50 non-
AI-affected controls.
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Results
Presenting clinical features
The proband of Family 1 is a 17-year-old male born of
unrelated parents of different ethnic origins (Pakistani
and English) (Fig. 1A). He presented to clinic with oral
features consistent with mutations in FAM20A (Fig. 1B).
The proband of Family 2 is a 15-year-old male born of
unrelated parents from Costa Rica (Fig. 2A). He pre-
sented to clinic with hypoplastic AI and mild gingival
enlargement suggestive of mutations in FAM20A
(Fig. 2B). In both families, no further symptoms were
reported and no other family members had enamel
abnormalities.
Genomic analysis
All coding exons and flanking intronic sequences of
FAM20A (NM_017565.3) were PCR amplified and
sequenced directly by Sanger sequencing in both families.
In Family 1, this identified a novel heterozygous missense
variant (c.1294G>A; p.A432T) in exon 9 (Fig. 1C). This var-
iant is not present in dbSNP 138 and alters a residue that is
fully conserved in orthologues and FAM20B (Fig. S1). The
variant was predicted damaging by 4/5 bioinformatic predic-
tion software packages tested (Table S2). Segregation analy-
sis revealed that it was inherited from the maternal allele in
the proband (Fig. 1A). An unaffected sibling (II:1) had also
inherited the variant. No additional variants were identified
in FAM20A nor its closest relative FAM20C, as would be
expected for a recessive disease.
To determine whether a second mutation affecting
splicing was present, leukocyte RNA from the affected
individual and his father was obtained and first-strand
cDNA synthesis performed. RT-PCR across FAM20A
revealed no aberrant splicing. However, unexpectedly the
c.1294G>A variant appeared homozygous in the cDNA of
the proband (Fig. 1C). As the father is not a carrier of
the c.1294G>A variant, a common SNP (c.1589T>C,
p.L530S, rs2907373) in FAM20A exon 11 was genotyped
instead. This was found to be heterozygous in the geno-
Figure 1. Dental phenotype and genetic analysis of Family 1. (A) Pedigree of Family 1 showing affected (shaded) and unaffected (unshaded)
members of the family. The segregation of the wild-type (+) and missense variant (c.1294G>A, NM_017565.3) p.A432T (mut) is shown below
each family member. (B) Photograph (top) and dental X-ray (bottom) showing the hypoplastic enamel phenotype of individual II:4. (C) Sequence
electropherograms from the affected individual (II:4) showing the wild-type allele (top), c.1294G>A mutation in genomic DNA (center) and in the
cDNA (bottom). The mutation is heterozygous in gDNA but homozygous in the cDNA suggesting the wild-type allele is not transcribed.
Sequencing of the FAM20A polymorphism (c.1589T>C, NM_017565.3; p.L530S) in the unaffected father (I:1), who does not carry the
c.1294A>G mutation, also showed it to be heterozygous in the genomic DNA (center) but homozygous in the cDNA (bottom), which is consistent
with one the allele not being transcribed.
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mic DNA but homozygous in cDNA (Fig. 1C). These
observations are consistent with only a single FAM20A
allele being transcribed in the father, and the same phe-
nomenon is evident in the affected son. In order to find
an explanation for the failure in the transcription of an
allele, we sequenced both 5ꞌ and 3ꞌ UTRs as well as con-
served regions located 5ꞌ to FAM20A. No variation which
could potentially cause a failure in transcription was iden-
tified. Despite further investigation by CNVseq of the
affected individual no explanation could be identified for
the lack of transcription.
In Family 2, screening of FAM20A identified a novel het-
erozygous missense variant (c.988T>C; p.C330R) in exon 7
(Fig. 2C) that is absent in dbSNP 138 and is fully con-
served in orthologues and paralogues (Fig. S1). This was
predicted to be damaging by all bioinformatic prediction
software tested (Table S2). Segregation of this variant
revealed that it was inherited from the mother. An unaf-
fected sibling (II:1) was also heterozygous for it, but as with
Family 1, no further variants were identified in FAM20A,
or its paralogue FAM20C. Screening of leukocyte cDNA
also revealed no observable sequence abnormalities, with
the FAM20A variant being heterozygous in the cDNA of
the proband as well as in the genomic DNA.
To determine whether the second mutation was a copy
number variation, we performed low-coverage whole gen-
ome sequencing (CNVseq) on genomic DNA of the
affected individual. These data revealed increased dosage
(1.5 9 diploid) for a ~54.7 kb segment spanning the first
four exons of FAM20A (approximately chr17:66,543,172-
66,597,963; Fig. S2). To verify this result, whole exome
sequencing was performed on a second aliquot of DNA
from the same individual. The resulting data were aligned
to the human hg19 genome and dosage analysis was per-
formed using FishingCNV by comparing this sample to a
cohort of 50 non-AI-affected controls. Exomes from all
controls and the AI-affected sample had been captured,
sequenced and analyzed using consistent methodologies
to ensure that resulting files were comparable. This
verified the presence of a duplication across FAM20A
(spanning an approximate genomic location between
chr17:66,548,013-66,596,807) with a Holm adjusted P-value
of 1.2791011 (Table 1).
Renal evaluation
In light of molecular findings, both probands were
assessed by pediatric nephrology specialists. The proband
Figure 2. Dental phenotype and genetic analysis of Family 2. (A) Pedigree of Family 2 showing affected (shaded) and unaffected (unshaded)
individuals. The segregation of the wild-type (+) and missense variant (c.988T>C, NM_017565.3) p.C330R (mut) is shown below each family
member. (B) Photograph (top) and dental imaging (bottom: left, panoramic; right, cone beam CT) showing the hypoplastic enamel phenotype
and on the clinical image, mild gingival enlargement of individual II:2. (C) Electropherogram showing the wild-type allele (top) and heterozygous
c.988T>C mutation (bottom) identified in Family 2 (top).
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of Family 1 was assessed at the age of 15 and the proband
of Family 2 was assessed at the age of 13. Investigations
included urinalysis, blood biochemistry, and renal ultra-
sound. No abnormal findings were noted.
Discussion
A distinctive clinical phenotype can be indicative of the
causative mutated gene, however, Sanger sequencing and
WES will not identify all disease-causing mutations. In
our cohort of eight families with orodental features con-
sistent with biallelic mutations in FAM20A, six had biall-
elic FAM20A mutations (Jaureguiberry et al. 2012). Each
of the remaining two families had single heterozygous
missense FAM20A mutations. We hypothesized that
within the spectrum of clinical features associated with
biallelic FAM20A mutations, a second mutation should be
present in each family that was not detectable by Sanger
sequencing. This was important to investigate given the
potential for renal involvement in the absence of all the
orodental features that may be present.
Further analysis of the FAM20A locus revealed that the
affected individual in Family 1 has inherited a paternal
allele that does not express a FAM20A transcript, leaving
only the maternal allele carrying a missense mutation
present in mRNA from whole blood. In Family 2 a
~54.7 kb duplication encompassing exons 1–4 of FAM20A
was identified as the second pathogenic mutation by
CNVseq.
Regulating transcription in many differentiated cell
types is an intricate task that requires a combination of
multiple different transcriptional regulatory proteins. Cis-
acting regulatory sequences (e.g., the TATA box) are
located adjacent to the genes they regulate, and are
responsible for binding of RNA polymerase. Additionally,
remote enhancers (RE’s) exist which are located further
away from the target gene but are equally vital to tran-
scription. It is therefore possible that mutation of such an
RE for FAM20A is present in Family 1, preventing tran-
scription of FAM20A. Previous studies have found RE’s
as far as 20 kb away from the target gene meaning their
identification can be difficult (Ghiasvand et al. 2011). In
this study, we attempted to identify promoter or enhancer
regions nearby to FAM20A, however, sequencing of these
regions were negative or inconclusive. The reason for the
unexpressed FAM20A allele in Family 1 therefore remains
elusive.
Whole genome sequencing (WGS) is increasingly used
for the analysis of DNA. Compared to WES, a wider vari-
ety of analyses can be performed, in part due to bias in
PCR amplification of individual exons in WES, which
leads to a heterogeneous profile of read coverage
compared to WGS (Gilissen et al. 2014; Meynert et al.
2014). Low-coverage whole genome sequencing is a
Table 1. List of regions with significant P-values (<0.05) following analysis of WES data using FishingCNV.
Location Gene Seg.mean P-value Adjusted P-value
chr11:22396300–22399286 SLC17A6 0.5547 9.50E-23 2.16E-19
chr17:66548013–66596807 FAM20A 0.5526 5.59E-15 1.27E-11
chr2:152235877–152267041 TNFAIP6 0.3731 2.18E-08 4.95E-05
chr2:196915910–196922840 DNAH7 0.5968 1.51E-07 0.000343691
chr17:57663513–57676844 DHX40 0.6386 2.78E-07 0.000630243
chr2:216226277–216226802 FN1 0.3568 9.74E-07 0.002208401
chr2:223806214–223806372 ACSL3 0.6371 8.86E-07 0.002009279
chr2:234178647–234178713 ATG16L1 0.7008 8.56E-07 0.001942038
chr17:78360489–78362489 RNF213 0.666 1.20E-06 0.00272912
chr2:204131236–204154599 CYP20A1 0.3354 2.19E-06 0.004967592
chr11:46702036–46703732 ARHGAP1 0.3511 2.57E-06 0.005813784
chr10:127422640–127426558 C10orf137 0.2957 2.87E-06 0.006508269
chr13:33249980–33250096 PDS5B 0.7288 4.22E-06 0.009545158
chr11:68350510–68350597 PPP6R3 0.5933 4.58E-06 0.01036926
chr22:42293055–42294785 SREBF2 0.6842 5.74E-06 0.01297131
chr17:79768700–79769007 GCGR 0.661 6.78E-06 0.015316085
chr1:243736227–243736350 AKT3 0.6555 8.54E-06 0.019287744
chr11:10820538–10820660 EIF4G2 0.625 8.97E-06 0.020264384
chr3:197701912–197702982 LMLN 0.442 1.02E-05 0.022952466
chr20:36561940–36561991 VSTM2L 0.625 1.11E-05 0.025099307
chr5:102490373–102490647 PPIP5K2 0.7072 1.67E-05 0.037756914
chr7:31016895–31016937 GHRHR 0.6681 1.97E-05 0.04446605
Regions are arranged in ascending order of adjusted P-value. Only regions with significant Holm adjusted P-values are shown. Seg.mean repre-
sents the mean log-ratio of coverage between the 50 control exome BAM files and the affected exome BAM file.
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reliable alternative to array comparative genomic hybrid-
ization for detecting large (>40 kb) structural variations
that is comparable in cost (Hayes et al. 2013). In this
study, CNVseq of an affected individual from Family 2
revealed a large duplication spanning FAM20A. Whole
exome sequencing of the proband confirmed the presence
of the putative duplication using an alternative wet-labo-
ratory technique and informatics algorithm. It is likely
that the falling cost of DNA sequencing will enable WGS
to be carried out at sufficient depth for it to be used as a
first line investigation. This would allow a dosage analysis
such as CNVseq to be undertaken concurrently with tra-
ditional point mutation or small insertion deletion variant
detection (Meynert et al. 2014). Furthermore, the recent
implementation of paired-end 250-bp HiSeq read lengths
may make it possible to identify breakpoint-spanning
reads, thus allowing the characterization of duplications
such as that reported for Family 2 to be mapped at nucle-
otide resolution.
Both missense variants identified in this study are in
the highly conserved predicted kinase domain of FAM20A
(based on homology to FAM20C) (Tagliabracci et al.
2012). Amino acid p.C330 is one of 12 cysteine residues
in FAM20A, all of which are fully conserved in ortho-
logues and paralogues. Cysteine residues form disulfide
bonds which play a key role in forming the specific ter-
tiary structure of the mature protein, so substitution of
p.C330 is likely to affect the protein structure. Residue
p.A432 lies within the Greek key domain at the C-termi-
nus of FAM20A, which is commonly found in c-crystal-
lins of the human lens and plays a key role in binding
calcium (Rajini et al. 2001). The substitution of a nonpo-
lar alanine with a polar threonine is likely to interfere
with this domain.
In light of the ERS clinical phenotype both families in
this study underwent renal evaluation by nephrology spe-
cialists after confirmation of biallelic FAM20A mutations.
No renal abnormalities were observed. This might imply
a correlation between milder missense mutations and lack
of nephropathology, but previous reported findings do
not support this hypothesis. The absence of a clear rela-
tionship between FAM20A genotype and renal phenotype
may reflect the influence of genetic modifiers or environ-
mental factors such as diet. Given the progressive nature
of the renal phenotype, a single renal assessment in child-
hood should not be interpreted as an absence of renal
involvement. Ongoing monitoring is indicated until there
is a better understanding of how to predict if and when
renal nephrocalcinosis of clinical significance will develop.
In summary, we investigated two families with a dis-
tinctive orodental phenotype previously associated with
recessive mutations in FAM20A, in whom only a single
missense mutation had been identified by Sanger sequenc-
ing. Screening of FAM20A cDNA in family 1 revealed that
the apparently wild-type allele was not transcribed,
whereas CNVseq of an affected individual from Family 2
revealed a large duplication encompassing exons 1–4 of
FAM20A. These findings confirm the link between biall-
elic FAM20A mutations and the characteristic oral pheno-
type and give insights into the classes of mutations
missed by the most commonly used mutation screening
techniques, together with possible methodologies for
identifying them. This insight informed renal assessment
and ongoing clinical care.
Acknowledgments
The authors wish to thank the families for their participa-
tion in this study. This study was supported by grants
from The Wellcome Trust (to A. J. M., and C. F. I. grant
# 093113), the Sir Jules Thorn Award for Biomedical
Research (to C. F. I. and D. T. B. grant # JTA/09), and
the Medical Research Council (to I. M. C. and D. T. B.
grant # MR/LO1629X/1).
Conflict of Interest
The authors declare no conflict of interest.
References
Acevedo, A. C., J. A. Poulter, P. G. Alves, C. L. de Lima, L. C.
Castro, P. M. Yamaguti, et al. 2015. Variability of systemic
and oro-dental phenotype in two families with non-lethal
Raine syndrome with FAM20C mutations. BMC Med.
Genet. 16:8. doi: 10.1186/s12881-015-0154-5 [Epub ahead of
print].
Cabral, R. M., M. Kurban, L. Rothman, M. Wajid, Y.
Shimomura, L. Petukhova, et al. 2013. Autosomal recessive
gingival hyperplasia and dental anomalies caused by a 29-
base pair duplication in the FAM20A gene. J. Hum. Genet.
58:566–567.
Cherkaoui Jaouad, I., M. El Alloussi, S. Chafai El Alaoui, F. Z.
Laarabi, J. Lyahyai, and A. Sefiani. 2015. Further evidence
for causal FAM20A mutations and first case of amelogenesis
imperfecta and gingival hyperplasia syndrome in Morocco: a
case report. BMC Oral Health 15:14.
Cho, S. H., F. Seymen, K. E. Lee, S. K. Lee, Y. S. Kweon, K. J.
Kim, et al. 2012. Novel FAM20A mutations in hypoplastic
amelogenesis imperfecta. Hum. Mutat. 33:91–94.
Cui, J., J. Xiao, V. S. Tagliabracci, J. Wen, M. Rahdar, and J.
E. Dixon. 2015. A secretory kinase complex regulates
extracellular protein phosphorylation. Elife 4:e06120. doi:
10.7554/eLife.06120.
de la Dure-Molla, M., M. Quentric, P. M. Yamaguti, A. C.
Acevedo, A. J. Mighell, M. Vikkula, et al. 2014.
Pathognomonic oral profile of Enamel Renal Syndrome
548 ª 2015 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
FAM20A Mutations Missed by Sanger Sequencing J. A. Poulter et al.
(ERS) caused by recessive FAM20A mutations. Orphanet. J.
Rare Dis. 9:84.
Ghiasvand, N. M., D. D. Rudolph, M. Mashayekhi, J. A. T.
Brzezinski, D. Goldman, and T. Glaser. 2011. Deletion of a
remote enhancer near ATOH7 disrupts retinal neurogenesis,
causing NCRNA disease. Nat. Neurosci. 14:578–586.
Gilissen, C., J. Y. Hehir-Kwa, D. T. Thung, M. van de Vorst,
B. W. van Bon, M. H. Willemsen, et al. 2014. Genome
sequencing identifies major causes of severe intellectual
disability. Nature 511:344–347.
Hayes, J. L., A. Tzika, H. Thygesen, S. Berri, H. M. Wood, S.
Hewitt, et al. 2013. Diagnosis of copy number variation by
Illumina next generation sequencing is comparable in
performance to oligonucleotide array comparative genomic
hybridisation. Genomics 102:174–181.
Jaureguiberry, G., M. de la Dure-Molla, D. Parry, M. Quentric,
N. Himmerkus, T. Koike, et al. 2012. Nephrocalcinosis
(enamel renal syndrome) caused by autosomal recessive
FAM20A mutations. Nephron Physiol. 122:1–6.
Kantaputra, P. N., C. Bongkochwilawan, M. Kaewgahya, A.
Ohazama, H. Kayserili, A. P. Erdem, et al. 2014a. Enamel-
Renal-Gingival syndrome, hypodontia, and a novel FAM20A
mutation. Am. J. Med. Genet. A 164A:2124–2128.
Kantaputra, P. N., M. Kaewgahya, U. Khemaleelakul, P.
Dejkhamron, S. Sutthimethakorn, V. Thongboonkerd, et al.
2014b. Enamel-renal-gingival syndrome and FAM20A
mutations. Am. J. Med. Genet. A 164A:1–9.
Li, H., and R. Durbin. 2009. Fast and accurate short read
alignment with Burrows-Wheeler transform. Bioinformatics
25:1754–1760.
Li, H., B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N.
Homer, et al. 2009. The sequence alignment/Map format
and SAMtools. Bioinformatics 25:2078–2079.
Meynert, A. M., M. Ansari, D. R. Fitzpatrick, and M. S.
Taylor. 2014. Variant detection sensitivity and biases in
whole genome and exome sequencing. BMC Bioinformatics
15:247.
O’Sullivan, J., C. C. Bitu, S. B. Daly, J. E. Urquhart, M. J.
Barron, S. S. Bhaskar, et al. 2011. Whole-Exome sequencing
identifies FAM20A mutations as a cause of amelogenesis
imperfecta and gingival hyperplasia syndrome. Am. J. Hum.
Genet. 88:616–620.
Rajini, B., P. Shridas, C. S. Sundari, D. Muralidhar, S.
Chandani, F. Thomas, et al. 2001. Calcium binding
properties of gamma-crystallin: calcium ion binds at the
Greek key beta gamma-crystallin fold. J. Biol. Chem.
276:38464–38471.
Shi, Y., and J. Majewski. 2013. Fishing CNV: a graphical
software package for detecting rare copy number variations
in exome-sequencing data. Bioinformatics 29:1461–1462.
Simpson, M. A., R. Hsu, L. S. Keir, J. Hao, G. Sivapalan, L. M.
Ernst, et al. 2007. Mutations in FAM20C are associated with
lethal osteosclerotic bone dysplasia (Raine syndrome),
highlighting a crucial molecule in bone development. Am. J.
Hum. Genet. 81:906–912.
Tagliabracci, V. S., J. L. Engel, J. Wen, S. E. Wiley, C. A.
Worby, L. N. Kinch, et al. 2012. Secreted kinase
phosphorylates extracellular proteins that regulate
biomineralization. Science 336:1150–1153.
Venkatraman, E. S., and A. B. Olshen. 2007. A faster circular
binary segmentation algorithm for the analysis of array
CGH data. Bioinformatics 23:657–663.
Volodarsky, M., U. Zilberman, and O. S. Birk. 2015. Novel
FAM20A mutation causes autosomal recessive amelogenesis
imperfecta. Arch. Oral Biol. 60:919–922.
Wang, S. K., P. Aref, Y. Hu, R. N. Milkovich, J. P. Simmer,
M. El-Khateeb, et al. 2013. FAM20A mutations can cause
enamel-renal syndrome (ERS). PLoS Genet. 9:e1003302.
Wang, S. K., B. M. Reid, S. L. Dugan, J. A. Roggenbuck, L.
Read, P. Aref, et al. 2014. FAM20A mutations associated
with enamel renal syndrome. J. Dent. Res. 93:42–48.
Watson, C. M., L. A. Crinnion, A. Tzika, A. Mills, A. Coates,
M. Pendlebury, et al. 2014. Diagnostic whole genome
sequencing and split-read mapping for nucleotide resolution
breakpoint identification in CNTNAP2 deficiency syndrome.
Am. J. Med. Genet. A 164:2649–2655.
Wood, H. M., O. Belvedere, C. Conway, C. Daly, R. Chalkley,
M. Bickerdike, et al. 2010. Using next-generation sequencing
for high resolution multiplex analysis of copy number
variation from nanogram quantities of DNA from formalin-
fixed paraffin-embedded specimens. Nucleic Acids Res. 38:
e151.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Table S1. Primers designed using ExonPrimer to amplify
the exons and flanking intronic sequence of FAM20A
(NM_017565.3) and FAM20C (NM_020223.3).
Table S2. Summary of bioinformatic analyses undertaken
to predict the pathogenic nature of the missense muta-
tions identified in FAM20A (NP_060035).
Figure S1. Conservation of the missense variants identi-
fied in this study.
Figure S2. Identification of a heterozygous duplication in
FAM20A of Family 2.
549ª 2015 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
J. A. Poulter et al. FAM20A Mutations Missed by Sanger Sequencing
